Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study
Go back to Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 81.82 +0.78 (0.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.04 | 52 Week High | $8.22 | |||
| Open | $82.57 | 52 Week Low | $3.07 | |||
| Day High | $84.55 | P/E | N/A | |||
| Day Low | $79.80 | EPS | $-1.30 | |||
| Volume | 3,863,403 | |||||
